On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture
Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.
Clinical Trial Materials
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Aseptic Processing | Biologics, Proteins, Vaccines | Capsules | Clinical Trial Materials | Clinical Trials | Fill/Finish | Injectables | Lyophilization | Parenterals | Validation | Vials
Jubilant HollisterStier CMO
Jubilant HollisterStier Contract Manufacturing & Services is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile and non-sterile topicals and liquids.Marcy Edwards, Marketing Manager 04.16.21
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Facilities | Industry News | Lyophilization
Catalent Adds Cryogenic Capabilities at Philadelphia Facility
Bolsters clinical supply services at site to meet growing demand for cell and gene therapy development.Tim Wright, Editor, Contract Pharma 04.15.21
-
Breaking News | Clinical Trial Materials | Industry News | Promotions & Moves | Solid Dosage/Creams/Ointments
Metrics Names Stephanie Emory Associate Director of Pharma Development
Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.Tim Wright, Editor, Contract Pharma 04.15.21
-
Analytical Services | Breaking News | Clinical Trial Materials | Drug Development | Industry News
Ascendia Pharmaceuticals Poised for Expansion
CDMO secures growth equity investment from Signet Healthcare Partners.Tim Wright, Editor, Contract Pharma 04.09.21
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Alkermes, Merck Enter Clinical Trial and Supply Agreement
To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.Tim Wright, Editor, Contract Pharma 04.07.21
-
Clinical Trial Materials | Drug Development | Formulation Development
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Industry News
PCI Pharma Services Expands Cold Chain Clinical Supply Storage
Adds significant capacity and several new cold chain storage conditions, which now include temperatures from controlled room temperature to -80°C.Kristin Brooks 03.16.21
-
Breaking News | Clinical Trial Materials | CRO News
LabConnect Expands Johnson City Facility
Central lab to add 20,000 sq.-ft., tripling kit building capacity for complex clinical studies along with other planned operational improvements.Kristin Brooks 03.16.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
NJ-based cell and gene therapy development and manufacturing center to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.Kristin Brooks 03.16.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.Kristin Brooks 02.22.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
RedHill and Cosmo Strengthen Manufacturing Agreements
Secures manufacturing capacity of Movantik for opioid-induced constipation and RHB-204, currently in a Phase 3 study for pulmonary NTM disease.Tim Wright, Editor, Contract Pharma 02.19.21
-
APIs | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cascade Chemistry Begins $14M cGMP Mfg. Capacity Expansion
Will triple floor space and increase manufacturing capacity for APIs for clinical trial materials and ultimately commercial production.Kristin Brooks 02.18.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
For EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody.Tim Wright, Editor, Contract Pharma 02.12.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Recipharm Bolsters Biologics Offering
Extends manufacturing license to include immunology products at clinical and commercial scales, in both freeze-dried and liquid forms.Kristin Brooks 02.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
Companies join forces in cell therapy applications and commercial-scale manufacturing.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal
Will deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.Tim Wright, Editor, Contract Pharma 02.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Catalent, Decibel Team Up for Hearing Loss Treatment
Enter development and manufacturing agreement for dual-vector gene therapy for the treatment of congenital hearing loss.Tim Wright, Editor, Contract Pharma 02.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
